News
ctDNA unreliable for detecting CRC recurrence after surgery
Two ctDNA tests used for this purpose are marketed in the United States.
News
FDA approves new immunotherapy combo for metastatic melanoma
Approval is based on findings that show median progression-free survival of 10.1 months.
News
As predicted: jump in metastatic prostate cancer diagnoses
Concerns over unnecessary prostatectomies took precedence over the benefits of screening for early high-risk disease.
News
Wake Forest Cancer Center director fired, advisory board resigns
The mass resignation of an EAB, a panel of outside experts that help shepherd cancer centers through the NCI grant process, is “highly unusual.”...
News
Active surveillance or maintenance after chemo induction in metastatic CRC?
Although maintenance strategies have typically demonstrated a PFS benefit, that advantage may come at “the expense of ongoing ... toxicity.”
News
Women at higher risk of serious adverse events from cancer therapy
As cancer treatment becomes increasingly individualized, “sex may be an important consideration.”
News
Increase in late-stage cancer diagnoses after pandemic
“Patients who have delayed preventative care during the pandemic should be encouraged to resume treatment as soon as possible.”
News
New PET tracer detects more metastases in cancer patients
“This may also mark the arrival of a new era in nuclear medicine where molecular imaging helps visualize and characterize the entire tumor burden...
News
EMA panel endorses two cancer drugs, one sickle cell drug
Tepotinib for NSCLC, enfortumab vedotin for urothelial cancer and voxelotor for sickle cell disease are currently approved in the U.S.
News
‘First reliable estimate’ of breast cancer metastasis
The overall risk of metastasis is between 6% and 22%, with younger women having a higher risk.
News
Luminal, basal groupings could change metastatic prostate cancer treatment
“These subtypes represent a potentially powerful tool for personalized therapeutic decision-making that may improve outcomes in metastatic mCRPC...
News
Watchful waiting in BCC: Which patients can benefit?
A study published in JAMA Dermatology sheds light on which patients with BCC may be appropriate candidates for watchful waiting.